Androgen Deprivation Therapy: Appropriate Patients, Timing to Initiate ADT, and Complications

Amirali H. Salmasi, Neal Patel, Isaac Kim

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Androgen deprivation therapy (ADT) still remains the foundation of high-risk and metastatic prostate cancer treatment. Since the discovery of the androgen-dependent nature of prostate cancer, ADT has been used in various treatment settings. ADT is used as an adjuvant treatment with radical prostatectomy, in combination with radiation, or as a palliative option for metastatic disease. Based on the clinical context, the optimal timing of ADT varies. More recently the role of intermittent ADT has also been shown to improve quality of life while reducing cost of treatment. However, ADT is associated many significant complications that affects many organ systems. These range from cardiovascular and metabolic abnormalities to decreased bone density and cognitive and emotional disturbances. It is important to understand not only the role and appropriate timing of ADT use in the treatment of prostate cancer but also the need to counsel patients regarding potential complications and side effects of this treatment.

Original languageEnglish (US)
Title of host publicationProstate Cancer
Subtitle of host publicationScience and Clinical Practice: Second Edition
PublisherElsevier Inc.
Pages481-489
Number of pages9
ISBN (Print)9780128000779
DOIs
StatePublished - Jan 1 2016

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Keywords

  • Adverse effects
  • Hormonal therapy
  • Prostate cancer

Fingerprint Dive into the research topics of 'Androgen Deprivation Therapy: Appropriate Patients, Timing to Initiate ADT, and Complications'. Together they form a unique fingerprint.

Cite this